ARS Pharmaceuticals (SPRY) Q4 2025 Earnings

10NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.52
-0.19
0.15
0.48

Details

Expected EPS
-0.453783
Actual EPS
-0.52
Surprise EPS
-0.07
Surprise Percent
+14.59%

Description

ARS Pharmaceuticals (SPRY) has reported earnings of -0.52 per share for Q4 2025.

0 Comments

Share your thoughts